[Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease].

Saved in:
Bibliographic Details
Title: [Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease].
Authors: Shamkhalova MS; Endocrinology Research Centre., Sukhareva OY; National Medical Research Center for Endocrinology., Shestakova MV; Endocrinology Research Centre.
Source: Terapevticheskii arkhiv [Ter Arkh] 2022 Nov 22; Vol. 94 (10), pp. 1188-1196. Date of Electronic Publication: 2022 Nov 22.
Publication Type: English Abstract; Journal Article
Journal Info: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Electronic Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0040-3660
DOI:10.26442/00403660.2022.10.201883